Company profile
IQVIA Holdings Inc.
NYSE: IQV · Healthcare · Medical - Diagnostics & Research
#30 of 1,422 Healthcare companies by revenue50th-percentile growth
EA Score
79B+FH 78DQ 89GM 62SS 85
v0.1 · 65/100 weight · provisional
↑ workforce scale, market scale · ↓ balance-sheet leverage, 3-yr revenue growth
Methodology →Revenue TTM
$16.6B
Rev growth YoY (TTM)
+7.3%
Net income (FY)
$1.4B
Employees
93,000
as of 2026-08-04
Market cap
$38.4B
as of 2026-08-04
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$16.3B$16.3B2025
Net income$1.4B$1.4B2025
Operating income$2.2B$2.2B2025
Total assets$29.9B$29.9B2025
Liabilities$23.3B$23.3B2025
Equity$6.5B$6.5B2025
Revenue trend
FY2020 – FY2025 · USD
FY20
FY20
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Research And Development Solutions55%
Technology And Analytics Solutions41%
Contract Sales And Medical Solutions5%
By geography
Americas47%
EMEA32%
Asia Pacific21%
The read
What is IQVIA Holdings Inc.’s revenue?
IQVIA Holdings Inc. booked $16.3B in FY2025 revenue, growing 5.9% year over year — about the middle of the pack among Healthcare companies we track, at a 8.3% net margin.
Peers · Healthcare
GE HealthCare Technologies Inc.69BBoston Scientific Corporation88AUniversal Health Services, Inc.83B+Regeneron Pharmaceuticals, Inc.85AViatris Inc.63CLabcorp Holdings Inc.84B+Neighbors
Durham →Key facts
CEOAri Bousbib
SectorHealthcare
IndustryMedical - Diagnostics & Research
HeadquartersDurham, NC
ExchangeNYSE: IQV
Employees93,000
IPO date2013-05-09
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.